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ABSTRACT
Introduction: Cardiovascular disease is one of the main causes for Turner syndrome (TS) mor-
tality and the evaluation of its risk factors such as excess body fat and its distribution is conside-
red one of the major aspects of the adult patient care. Objective: To develop and validate a spe-
cific bioelectrical impedance analysis (BIA) equation to predict body composition in TS patients. 
Subjects and methods: Clinical and anthropometric data, dual-energy X-ray absorptiometry 
(DXA) for total fat-free mass (FFM) and BIA for resistance and reactance were obtained from 50 
adult TS patients. Linear regression analysis was performed with multiple clinical and BIA data 
to obtain a predicting equation. Results: The equation developed to estimate FFM in adult TS 
patients showed great consistency with DXA, elevated correlation (r = 0.974) and determination 
(r2 = 0.948) coefficients and an adequate standard error estimate (SEE = 1.52 kg). Conclusions: 
The specific equation developed here allowed making an adequate FFM estimate in adult TS 
patients. Arq Bras Endocrinol Metab. 2010;54(1):24-9
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RESUMO 
Introdução: A doença cardiovascular é uma das principais causas de mortalidade na síndrome 
de Turner (ST) e a avaliação de seus fatores de risco, como excesso e distribuição de gordura 
corporal, é considerada uma das principais metas da assistência às pacientes adultas. Objetivo: 
Desenvolver e validar uma equação de análise por bioimpedanciometria específica para estimar 
massa magra na ST. Sujeitos e métodos: Foram obtidos dados clínicos, antropométricos, den-
sitometria para massa magra total e bioimpedanciometria para resistência e reactância de 50 
mulheres adultas com ST. Para obter uma equação preditora, foi realizada análise de regressão 
linear com múltiplos dados clínicos e da bioimpedanciometria. Resultados: A equação desen-
volvida para estimar massa magra na ST demonstrou grande concordância com a densitome-
tria, elevados coeficientes de correlação (r = 0,974) e determinação (r2 = 0,948) e um adequado 
erro padrão da estimativa (SEE = 1,52 kg). Conclusões: A equação desenvolvida possibilitou 
uma adequada estimativa da massa magra em adultas com ST. Arq Bras Endocrinol Metab. 2010;54(1):24-9
Descritores
Síndrome de Turner; composição corporal; densitometria; impedância elétrica
InTRODUCTIOn
Turner syndrome (TS) is a genetic condition, in which the complete or partial loss of one of the sex chro-
mosomes determines the birth of individuals with female 
phenotype and remarkable clinical findings, such as low 
stature and gonadal dysgenesis (1). In the last ten years, 
the knowledge that cardiovascular disease stands as one of 
the main causes for TS mortality has intensified the evalu-
ation of its several risk factors (2). In this context, excess 
body fat and its distribution have also been explored (3).
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Bioelectrical impedance analysis (BIA) is a simple, 
safe, inexpensive and non-invasive method to estimate 
fat-free mass (FFM), total body water, and fat mass (4). 
This method is particularly useful in determining body 
compartments in studies of large population samples (5). 
BIA is based on statistical equations developed from 
data collected in a given population group. The collec-
tion of anthropometric data as well as body resistance 
and reactance to a low-voltage electric current in the 
present sample guarantees that the equation developed 
can be applied specifically to the originally evaluated 
population.
Multiple equations were developed for use with 
diverse population groups with different body char-
acteristics. Mathematic formulas were created for 
healthy populations of different ethnicities, different 
age groups, varied degrees of daily physical activity, 
and populations suffering from particular conditions 
and diseases (6,7). However, to date no equations have 
been developed specifically for predicting body compo-
sition in TS patients despite its particular anthropomet-
ric characteristics (8). 
Dual-energy X-ray absorptiometry (DXA) has in-
creasingly been viewed as a laboratory method for the 
estimation of total body fat. Based on the concept that 
photon attenuation is a function of tissue composition, 
this method was applied as gold standard for the valida-
tion of the regression equations for BIA fat-free predic-
tions (9).
The aim of the present study was to develop and 
validate a BIA equation for predicting body composi-
tion in TS patients using DXA as the reference method.
SUBjECTS AnD METhODS
Patients
The study included 50 TS patients, aged 18.4 to 58.5 
years, recruited from the Endocrinology Outpatient 
Clinic of Universidade Federal de São Paulo (Unifesp), 
Brazil. The TS patients selected for the present study 
had come to the clinic with complaints including short 
stature and sexual infantilism. A hormone profile of 
hypergonadotropic hypogonadism or an unexplained 
short stature led to cytogenetic evaluation. All patients 
included had complete epiphyseal fusion of the growth 
plates according to the Grewlich-Pyle atlas (10). None 
of them had clinically perceptible peripheral lymph-
edema. 
The study protocol was approved by the local ethics 
committee. All TS patients and/or their parents gave 
informed consent for the study.
Karyotype
Karyotypes were determined by standard analysis of pe-
ripheral blood lymphocytes, and the number of meta-
phases analyzed followed the criteria adopted by Hook 
for detecting 8% mosaicism in 40 metaphases, with a 
confidence interval of 95% (11).
Anthropometry
Stature was measured three times with a fixed stadiom-
eter, with 0.1 cm sensitivity, in shoeless patients. The 
average of three measurements was used for the analy-
sis. Weight was measured with an electronic scale with 
0.05 kg sensitivity, with patients wearing only under-
garments and no shoes.
Evaluation of body composition
Bioelectrical impedance analysis
Resistance and reactance were measured with a single-
frequency (50 kHz), four-channel bioimpedance ana-
lyzer (BIA 310, Biodynamics Corp., Seattle, WA, USA) 
according to the manufacturer’s instructions. The pro-
cedure was performed with fasting patients, lying down 
in a supine position on a bed with non-conductive sur-
face, with four superficial electrodes positioned on the 
dorsal surfaces of the right hand and foot, at the distal 
metacarpals and metatarsals, respectively, and between 
the distal prominences of the radius and the ulna at the 
wrist, and the medial and lateral malleoli at the ankle. 
Dual-energy X-ray absorptiometry
A DXA scanner (Hologic QDR 4500C, Hologic Inc, 
Bedford, MA, USA) was used for whole-body scan 
composition evaluation of the total and segmented soft 
section (arms, legs and torso).
Statistical analysis
Descriptive statistics was used for age, weight, height, 
body mass index (BMI), resistance and reactance pa-
rameters (BIA), fat-free body mass, total and perceptu-
al fat (DXA). With the data obtained by DXA as refer-
ence, stepwise multiple regression analysis was used to 
develop a predicting equation of the FFM for BIA. Pre-
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dicting variables gathered through BIA parameters and 
anthropometry were progressively added to the equa-
tion model, in order to obtain the highest level of cor-
relation and reduce the estimate margin of error. Bland 
and Altman analysis was used to assess the agreement 
between the FFM estimated by the regression equation 
developed and the one obtained by DXA. This analysis 
consists of establishing the joint mean of the difference 
between the results of the measurements obtained by 
both instruments used, followed by plotting the dif-
ference of each case individually. The BIAS, the con-
fidence interval for the agreement limit and finally the 
validity of the instrument studied were evaluated from 
the interval between two standard errors above and two 
standard errors below the mean difference (12).
Three validated equations to estimate FFM in popu-
lations without TS were applied to the present study 
sample in order to compare the FFM data obtained by 
DXA. The determination coefficient, the BIAS and the 
limits of agreement by the Bland and Altman analysis 
were used to compare the FFM results and differences 
from DXA obtained with the equations of Heitmann 
(13) [0.279 x stature2/resistance (cm2/ohms) + 0.181 x 
weight (kg) + 0.231 x stature (cm) - 0.077 x age (years) 
-14.94]; Segal and cols. (14) [0.00108 x stature (cm) 
- 0.0209 x resistance (ohms) + 0.23199 x weight (kg) - 
0.06777 X age (years) + 14.59453]; Kyle and cols. (15) 
[- 4.104 + 0.518 x stature2/resistance (cm2/ohms) + 
0.231 x weight (kg) + 0.13 x reactance (ohms)] and 
of this study. The significance level was set at p < 0.05.
RESUlTS
TS patients karyotypes were distributed as shown in 
table 1
The predicting equation developed to estimate the 
FFM of the 50 TS patients through BIA is described 
in table 2.
Evaluation of the relative importance of each varia-
ble individually and associated with the other variables 
in the equation is presented in table 3.
Bland and Altman’s analysis evaluating the BIA for-
mula applied to the full sample, and the scatter plot 
illustrating the correlation with the DXA findings are 
shown in figure 1. As per Bland and Altman’s analysis, 
the mean difference and standard deviation of the FFM 
obtained by DXA and BIA was 0.06 and 1.48 kg, re-
spectively, the agreement for the limit interval (2SD) 
being between +3 and -2.9 kg.
Table 1. Cytogenetic characterization of the TS patients studied
Karyotype n
45,X 36
45,X/46,XX 3
45,X/46,X,i(X)(q10) 3
45,X/46,XY 1
45,X/46,XX,+mar 1
45,X/46,XX,p+ 1
45,X/47,XXX 1
45,X/46,XX,add(X)(q22) 1
45,X/46,XX,add(15)(p11) 1
46,X,derX(p11.2) 1
46,X,idicX(q10) 1
Total 50
Table 2. Anthropometric data, BIA and DXA results from 50 TS patients 
studied
Variable Median Minimum Maximum
Age (years) 24.7 18.3 58.5
Weight (kg) 51.9 30.2 113.0
Stature (m) 1.43 1.26 1.61
BMI (kg/m2) 24.4 16.6 43.4
Resistance 652.5 451.0 815.0
Reactance 76.5 45.0 131.0
DXA total fat (g) 16,925.0 8,448.5 54,481.0
DXA fat-free mass (g) 33,472.3 21,713.1 58,964.8
Fat percentage (%) 33.0 21.3 48.0
BMI: body mass index; DXA: dual-energy X-ray absorptiometry.
Table 3. Relative importance of BIA variables in predicting FFM in Turner 
syndrome patients
Variable r r2 SEE p-value
S2/R 0.86 0.739 3.328 < 0.001
W 0.942 0.887 2.189 < 0.001
S 0.704 0.496 4.630 < 0.001
S2/R + W 0.966 0.933 1.701 < 0.001
S2/R + W + S 0.974 0.948 1.519 < 0.001
S2/R: stature2/resistance; W: weight; S: stature; r: correlation coefficient; r2: determination 
coefficient; SEE: standard error estimation.
The determination coefficient and agreement ana-
lyzed by Bland and Altman’s method for the FFM of TS 
patients obtained by DXA and the estimates obtained 
with the regression equation for BIA of this study and 
with equations from three other studies are presented 
in table 4. 
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FAT-FREE MASS by BIA (g)
= -11.068 + 0.307 X S2/R (cm2/ohms) + 0.286 X weight.(kg) + 0.14 X stature.(cm)
FFM DXA measured (mean + SD) = 33.82 ± 6.45 kg
FFM BIA estimated (mean + SD) = 33.89 ±  6.29 kg  r = 0.974, SEE = 1.52 kg
N = 50
S2/R = stature2/resistance; r = correlation coefficient; SEE = standard error estimation. 
Figure 1. BIA-based FFM estimation equation and FFM mean (± SD) 
measured by DXA and estimated by BIA in the TS sample studied.
Figure 2. Scatter plot illustrating the BIA correlation with the DXA(A). Bland 
and Altman analysis evaluating the BIA formula applied to the full sample (B).
DISCUSSIOn
Previous studies that evaluated body composition in 
adult women with TS and estimated the percentage 
of body fat distribution and FFM have utilized several 
methods and equipment. There have been evaluations 
performed by skinfold measurement (16,17), ultraso-
Table 4. Determination coefficient, agreement limits and BIAS of the 
sample analysis with the present study equation and three other ones
 Studies BIAS* (kg) Agreement limits (kg) r2
Present study 0.06 -2.89 to +3.02 0.948
Segal and cols. (14) -0.37 -3.89 to +3.15 0.925
Heitmann (13) 0.67 -3.83 to +5.18 0.889
Kyle and cols. (15) -1.35 -6.48 to +2.56 0.848
r2:  determination coefficient.
* Mean difference between the FFM measured by DXA and using the regression equations for BIA.
nography (18), DXA (19,20), BIA (21,22) and mag-
netic resonance imaging (23). If, on the one hand they 
produce high-quality information on the other some of 
these instruments are relatively expensive and have little 
mobility (24). BIA is characterized by being simple to 
perform, low-cost and of good mobility which singles 
it out for population studies which demand large sam-
ples and may require the displacement of researchers 
for field data collection. Previous studies which used 
BIA for body composition evaluation in TS did so us-
ing equations developed for normal populations or 
equations not made freely available by the bioelectrical 
impedance analyzer manufacturers (25,26). Based on 
multiple linear regression models the development of 
predicting equations is specific for the populations from 
which the original samples were collected. Population 
groups with particular characteristics determine the 
need for specific mathematic formulae. Knowing that 
BIA is based on the theoretical relationship between the 
volume of the organic conductor and its resistance to an 
established electric current and that, putting it simply, 
volume depends on the length and transversal area of 
that conductor, both height and other anthropometric 
body characteristics definitely influence its measuring 
(27). TS patients have physical characteristics that dis-
tinguish them from normal women. The differences in 
body proportions are remarkable. These patients have a 
low arm span, short stature and high bi-iliac diameters 
compared to normal women (28). These particular an-
thropometric measurements justify the need for specific 
BIA equations developed for this population group.
Considering that life expectancy of TS patients is 
reduced mainly due to cardiovascular disease and that 
the presence of risk factors associated to obesity is more 
prevalent than in women without this genetic alteration 
(29), validation of specific body composition analysis 
instruments is clearly needed.
In this study, performed in an adult population with 
TS we developed a predicting equation for FFM to be 
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used with BIA and compared it with three previously 
developed equations; however, appropriate for normal 
populations (without TS).
As in several equation validation studies for BIA, 
here the interaction of the ratio established between 
the square stature and resistance (S2/R) and anthro-
pometric data defined an equation with a high degree 
of agreement with the method used for comparison 
(DXA). In this equation, weight gave the greatest con-
tribution among the variables studied followed by the 
S2/R ratio. Combined they could explain more than 
90% of the FFM variance (r2 = 0.933). Stature was the 
only other variable that significantly contributed to the 
equation with increase of the multiple regression deter-
mination coefficient and with reduction of the standard 
estimation error (r2 = 0.948, SEE 1.519).
Regarding the size of the study sample, it can be 
considered adequate for the development of BIA equa-
tions taking into account prevalence of TS in the popu-
lation, 1:2500 to 1:3000 of live born girls, and their 
particular body characteristics (30). Nevertheless, the 
number of participants limited the possibility of validat-
ing the equation in a TS sample different from the one 
used to build the equation. This procedure could have 
enhanced the power of the developed equation.
In the TS sample studied, Bland and Altman's anal-
ysis used to compare FFM obtained by DXA with that 
obtained using the regression equation developed by 
us, and also those previously validated by Segal and 
cols. (14), Heitmann (13), and Kyle and cols. (15), an 
acceptable agreement was demonstrated for all compar-
isons made. As expected, the limits for the agreement 
and mean differences between FFM measured by DXA 
and that predicted by BIA were lower for the equation 
originated from the sample of TS women of this study. 
However, only validation of the equation developed in 
the present study in independent samples of TS women 
can determine if it is actually superior to other previ-
ously developed equations.
COnClUSIOn
To the best of our knowledge, the present study is the 
first to validate a specific equation for adult TS patients. 
Additional studies are necessary to confirm the validity 
of this equation.
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